After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
I learned a long time ago, don’t outthink it.
Earnings estimates for these five stocks improved a lot this year -- and the technical charts also say buy.
It's hard to be as bullish as Ball officials when the company's multiple is way above the norm.
Here are Monday's top research calls, including downgrades for Bristol-Myers Squibb, JPMorgan and Weyerhaeuser, and an upgrade for Merck.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.